Bristol-Myers liver cancer drug fails trial (Reuters)
Reuters – Bristol-Myers Squibb Co said on Thursday its liver cancer drug brivanib failed to meet the primary endpoint in a late-stage clinical trial.
Good Health is Your Greatest Wealth……Virgil
Reuters – Bristol-Myers Squibb Co said on Thursday its liver cancer drug brivanib failed to meet the primary endpoint in a late-stage clinical trial.